AdvertisementAstraZeneca COVID-19 Vaccine Trial Data Questioned By Safety BoardUpdated March 23, 2021Jaclyn DiazfacebookEmailThe National Institute of Allergy and Infectious Diseases said concerns were raised with the information released by AstraZeneca on initial clinical trial data. (AP)This article was originally published on March 23, 2021.
